Top 10 venture financing deals in worldwide pharmaceutical industry by value in 2014 (in million U.S. dollars)*

Total value of top pharmaceutical venture financing deals 2014 This statistic displays the value of the top 10 venture financing deals worldwide within the pharmaceutical industry in 2014. In that year, Juno Therapeutics, a biotechnology company was given a venture capital deal valued at 134 million U.S. dollars. In the biotechnology industry, many corporate investors are funding innovation and research, however, high regulations on the market has lowered returns and made venture capital funds less prominent in recent years in this market.
Show more
Loading statistic...
CompanyValue in million U.S. dollars
Alkermes250
NantWorks250
Intarcia Therapeutics200
Lexicon Pharm.150
Juno Therapeutics134
Idenix Pharm.107
Adaptimmune104
Paratek Pharm.93
Cell Medica80
Naurex80
CompanyValue in million U.S. dollars
Alkermes250
NantWorks250
Intarcia Therapeutics200
Lexicon Pharm.150
Juno Therapeutics134
Idenix Pharm.107
Adaptimmune104
Paratek Pharm.93
Cell Medica80
Naurex80
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment

Description

Source

More information

This statistic displays the value of the top 10 venture financing deals worldwide within the pharmaceutical industry in 2014. In that year, Juno Therapeutics, a biotechnology company was given a venture capital deal valued at 134 million U.S. dollars. In the biotechnology industry, many corporate investors are funding innovation and research, however, high regulations on the market has lowered returns and made venture capital funds less prominent in recent years in this market.
Show more
Release date
June 2015
Region
Worldwide
Survey time period
2014
Supplementary notes
* Includes investments in pharmaceutical and biotech companies. Does not include pure-play genomics or medical device companies. Includes Private Investment in Public Equity (PIPE). Deal value represents the total disclosed value. Deal count includes all deals regardless of whether the value was disclosed.
More information
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp

Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation

Statistics on "Pharmaceutical trends in Europe"
  • Overview
The most important statistics
  • European Pharmaceutical companies
  • Self-medication market
  • Employment
  • Clinical Trials
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics on the topic
Topics
About Statista
Learn more about how Statista can support your business.
Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News